A team of researchers at Kyoto University has uncovered why some stroke patients experience pain not just on one side of their body, but mysteriously on both sides—a baffling phenomenon known as mirror-image pain. The breakthrough, published in Communications Biology, reveals a molecular pathway that crosses the brain's corpus callosum like an unwanted messenger, spreading inflammation from the site of injury to the opposite hemisphere.
Stroke is already a devastating condition that disrupts the brain's normal function. Many patients experience pain in the limbs opposite to where their brain injury occurred, which is expected. But in rarer cases, pain develops on both sides of the body in a mirror-like pattern—and until now, scientists didn't fully understand how this happened.
The culprit is a lipid molecule called lysophosphatidic acid, or LPA. This molecule, which seeps out from damaged cell membranes and other cellular components after tissue injury, has long been suspected of fueling chronic pain. But the exact pathway remained a mystery. "The central question underlying our study is: why does pain occur after a stroke, and why does it sometimes spread to both sides of the body?" asks Hiroyuki Neyama, the first author of the study.
Using imaging mass spectrometry—a technique that measures molecules directly within brain tissue sections—the researchers mapped what happens after a stroke in mice. They watched LPA levels spike, then observed a precise sequence unfold: microglia (the brain's immune cells) became activated, inflammation propagated across the corpus callosum to the opposite side of the brain, and levels of PGE2, a pain-related molecule, surged. The result: bilateral pain.
What struck the team most was simply being able to see this process happen. "What impressed us most was our ability to visualize previously unseen inflammatory processes in the brain as molecular images of LPA and PGE2," says corresponding author Yuki Sugiura. For decades, scientists have theorized about how inflammation spreads in the brain, but directly visualizing it was nearly impossible—until now.
The findings carry immediate therapeutic implications. If LPA and microglial activation are the drivers of post-stroke pain, then blocking these mechanisms could offer relief to patients who currently have limited treatment options. The Kyoto team has already mapped out their next steps: testing whether this same pathological process contributes to neuroinflammation and chronic pain in conditions beyond stroke.
For the millions of stroke survivors worldwide living with pain, this research offers something precious: clarity about what's happening inside their brains, and a concrete target for future treatments. The breakthrough also underscores how modern imaging techniques—once relegated to research labs—are finally allowing scientists to see the invisible machinery of neuroinflammation in real time.